Intradigm Corporation's Series A Round

Intradigm Corporation raised a round of funding on May 23, 2006.

Intradigm is a private biotechnology company focused on the discovery, development and delivery of novel targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases. …

Articles about Intradigm Corporation's Series A Round: